07/20. Patient Counselling Information- (2020)- No.7. Amisulphide (BARTHEMSYS) -(Feb 2020).
Drug Name:
07/20. Patient Counselling Information- (2020)- No.7. Amisulphide (BARTHEMSYS) -(Feb 2020).
List Of Brands:
Indication Type Description:
Drug Interaction:
No.7. Amisulphide -(BARTHEMSYS)- (Feb 2020)
PATIENT COUNSELING INFORMATION
QT Prolongation- Instruct patients to contact their healthcare provider immediately if they perceive a change in their heart rate, if they feel lightheaded, or if they have a syncopal episode
Drug Interactions Advise patients to report to their healthcare provider if they are taking drugs which prolong the QT interval
Lactation- Women may consider reducing infant exposure through pumping and discarding breastmilk for 48 hours after BARHEMSYS administration
Distributed by Acacia Pharma Inc. 8440 Allison Pointe Blvd, Suite 100 Indianapolis, IN 46250 USA © 2020 Acacia Pharma Inc. All rights reserved. BAR-0001-USPI-02/2020